Garrett M. Brodeur

34.6k total citations · 11 hit papers
244 papers, 24.9k citations indexed

About

Garrett M. Brodeur is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Garrett M. Brodeur has authored 244 papers receiving a total of 24.9k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Neurology, 132 papers in Molecular Biology and 56 papers in Cancer Research. Recurrent topics in Garrett M. Brodeur's work include Neuroblastoma Research and Treatments (184 papers), Cancer, Hypoxia, and Metabolism (46 papers) and Cancer therapeutics and mechanisms (41 papers). Garrett M. Brodeur is often cited by papers focused on Neuroblastoma Research and Treatments (184 papers), Cancer, Hypoxia, and Metabolism (46 papers) and Cancer therapeutics and mechanisms (41 papers). Garrett M. Brodeur collaborates with scholars based in United States, Canada and Germany. Garrett M. Brodeur's co-authors include Robert C. Seeger, Manfred Schwab, Harold Varmus, J. Michael Bishop, Katherine K. Matthay, Akira Nakagawara, Naohiko Ikegaki, Susan L. Cohn, Daniel O. Stram and Hiroyuki Shimada and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Garrett M. Brodeur

239 papers receiving 24.4k citations

Hit Papers

Amplification of N- myc i... 1983 2026 1997 2011 1984 2003 1985 1999 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
    1984 1.8k citations Garrett M. Brodeur et al. profile →
  2. Neuroblastoma: biological insights into a clinical enigma
    2003 1.7k citations Garrett M. Brodeur profile →
  3. Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas
    1985 1.6k citations Garrett M. Brodeur et al. profile →
  4. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
    1999 1.4k citations Garrett M. Brodeur et al. profile →
  5. The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
    2008 1.3k citations Susan L. Cohn, Wendy B. London et al. Journal of Clinical Oncology profile →
  6. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour
    1983 1.2k citations Garrett M. Brodeur et al. profile →
  7. Expression of Multidrug Resistance Gene in Human Cancers
    1989 1.1k citations Garrett M. Brodeur et al. profile →
  8. The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
    2008 678 citations Garrett M. Brodeur, Wendy B. London et al. Journal of Clinical Oncology profile →
  9. Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human Neuroblastoma
    1993 552 citations Garrett M. Brodeur et al. profile →
  10. Degradation of nuclear oncoproteins by the ubiquitin system in vitro.
    1991 305 citations Garrett M. Brodeur et al. profile →
  11. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
    1984 252 citations Garrett M. Brodeur et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Garrett M. Brodeur 16.2k 14.4k 6.6k 5.2k 2.9k 244 24.9k
Robert C. Seeger 15.5k 1.0× 12.2k 0.9× 6.5k 1.0× 5.4k 1.0× 2.3k 0.8× 220 23.6k
Akira Nakagawara 7.0k 0.4× 11.4k 0.8× 4.4k 0.7× 5.3k 1.0× 1.5k 0.5× 347 18.0k
Nai‐Kong V. Cheung 7.7k 0.5× 6.8k 0.5× 3.0k 0.5× 5.5k 1.1× 1.3k 0.5× 392 16.7k
William A. Weiss 3.5k 0.2× 9.3k 0.6× 3.7k 0.6× 2.8k 0.5× 895 0.3× 268 15.3k
Kenneth Aldape 2.4k 0.1× 13.1k 0.9× 8.1k 1.2× 6.6k 1.3× 1.3k 0.4× 369 27.8k
Zhengping Zhuang 2.2k 0.1× 4.9k 0.3× 4.0k 0.6× 2.8k 0.5× 831 0.3× 321 12.3k
Mark W. Kieran 2.5k 0.2× 6.7k 0.5× 2.7k 0.4× 2.7k 0.5× 650 0.2× 268 14.9k
Richard J. Gilbertson 2.4k 0.1× 10.4k 0.7× 3.4k 0.5× 4.1k 0.8× 1.1k 0.4× 153 16.8k
Yusuke Nakamura 1.1k 0.1× 15.2k 1.1× 5.4k 0.8× 8.0k 1.5× 3.6k 1.2× 377 25.6k
Rameen Beroukhim 1.2k 0.1× 10.0k 0.7× 6.1k 0.9× 4.1k 0.8× 2.2k 0.8× 155 17.0k

Countries citing papers authored by Garrett M. Brodeur

Since Specialization
Citations

This map shows the geographic impact of Garrett M. Brodeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrett M. Brodeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrett M. Brodeur more than expected).

Fields of papers citing papers by Garrett M. Brodeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrett M. Brodeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrett M. Brodeur. The network helps show where Garrett M. Brodeur may publish in the future.

Co-authorship network of co-authors of Garrett M. Brodeur

This figure shows the co-authorship network connecting the top 25 collaborators of Garrett M. Brodeur. A scholar is included among the top collaborators of Garrett M. Brodeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrett M. Brodeur. Garrett M. Brodeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamihara, Junne, Jaclyn Schienda, Rose B. McGee, et al.. (2025). Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clinical Cancer Research. 31(9). 1573–1579. 1 indexed citations
2.
3.
Brodeur, Garrett M., Lisa Diller, Kim E. Nichols, et al.. (2025). Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions. Clinical Cancer Research. 31(13). 2581–2588. 1 indexed citations
4.
Rednam, Surya P., Junne Kamihara, Garrett M. Brodeur, et al.. (2025). Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma Syndromes. Clinical Cancer Research. 31(16). 3368–3376. 1 indexed citations
5.
Brzezinski, Jack, Gaëlle Bougeard, Garrett M. Brodeur, et al.. (2024). Update on Surveillance Guidelines in Emerging Wilms Tumor Predisposition Syndromes. Clinical Cancer Research. 31(1). 18–24. 2 indexed citations
6.
Kalish, Jennifer M., Gaëlle Bougeard, Garrett M. Brodeur, et al.. (2024). Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith–Wiedemann Syndrome and Other Predisposition Syndromes. Clinical Cancer Research. 30(23). 5260–5269. 9 indexed citations
7.
Kamihara, Junne, Lisa Diller, William D. Foulkes, et al.. (2024). Neuroblastoma Predisposition and Surveillance—An Update from the 2023 AACR Childhood Cancer Predisposition Workshop. Clinical Cancer Research. 30(15). 3137–3143. 6 indexed citations
8.
Hansford, Jordan R., Anirban Das, Rose B. McGee, et al.. (2024). Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors. Clinical Cancer Research. 30(11). 2342–2350. 9 indexed citations
9.
MacFarland, Suzanne P., Luke Maese, Surya P. Rednam, et al.. (2022). Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition. Cancer Prevention Research. 15(10). 645–652. 3 indexed citations
10.
MacFarland, Suzanne P., Radhika Iyer, Peng Guan, et al.. (2019). Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model. Molecular Cancer Therapeutics. 19(3). 920–926. 17 indexed citations
11.
Orienti, Isabella, Peng Guan, Venkatadri Kolla, et al.. (2019). <p>A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model</p>. Drug Design Development and Therapy. Volume 13. 4305–4319. 15 indexed citations
12.
Mussa, Alessandro, Kelly A. Duffy, Diana Carli, et al.. (2019). The effectiveness of Wilms tumor screening in Beckwith–Wiedemann spectrum. Journal of Cancer Research and Clinical Oncology. 145(12). 3115–3123. 20 indexed citations
13.
Alferiev, Ivan S., Peng Guan, Venkatadri Kolla, et al.. (2018). Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model. Clinical Cancer Research. 24(11). 2585–2593. 26 indexed citations
14.
Iyer, Radhika, Michael Chorny, Ivan S. Alferiev, et al.. (2015). Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma. Cancer Letters. 360(2). 205–212. 35 indexed citations
15.
Higashi, Mayumi, et al.. (2015). Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma. Molecular Cancer. 14(1). 150–150. 19 indexed citations
16.
García, Idoia, José Ríos, Gema Doménech, et al.. (2012). A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma. Clinical Cancer Research. 18(7). 2012–2023. 51 indexed citations
17.
Cole, Kristina A., Edward F. Attiyeh, Yaël P. Mossé, et al.. (2008). A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene. Molecular Cancer Research. 6(5). 735–742. 242 indexed citations
18.
Schneiderman, Jennifer, Wendy B. London, Garrett M. Brodeur, et al.. (2008). Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(6). 913–918. 50 indexed citations
19.
Bagatell, Rochelle, Wendy B. London, Susan L. Cohn, et al.. (2005). Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy. Journal of Clinical Oncology. 23(34). 8819–8827. 59 indexed citations
20.
Brodeur, Garrett M.. (1987). The Involvement of Oncogenes and Suppressor Genes in Human Neoplasia. Advances in Pediatrics. 34(1). 1–44. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert C. Seeger Breakdown of academic impact, for papers by Akira Nakagawara Breakdown of academic impact, for papers by Nai‐Kong V. Cheung Breakdown of academic impact, for papers by William A. Weiss Breakdown of academic impact, for papers by Kenneth Aldape Breakdown of academic impact, for papers by Zhengping Zhuang Breakdown of academic impact, for papers by Mark W. Kieran Breakdown of academic impact, for papers by Richard J. Gilbertson Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Rameen Beroukhim
Rankless by CCL
2026